标题
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
作者
关键词
Multiple sclerosis, Progression, Primary progressive, Secondary progressive, Therapeutics, Clinical trials
出版物
Neurotherapeutics
Volume 13, Issue 1, Pages 58-69
出版商
Springer Nature
发表日期
2016-01-05
DOI
10.1007/s13311-015-0409-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
- (2015) Orhun H. Kantarci et al. ANNALS OF NEUROLOGY
- Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis
- (2015) Gorm Pihl-Jensen et al. CNS DRUGS
- Progressive multiple sclerosis
- (2015) Daniel Ontaneda et al. CURRENT OPINION IN NEUROLOGY
- The crucial role of mast cells in blood–brain barrier alterations
- (2015) Domenico Ribatti EXPERIMENTAL CELL RESEARCH
- Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
- (2015) Simon Zhornitsky et al. Journal of Neuroinflammation
- A much-needed focus on progression in multiple sclerosis
- (2015) Alan J Thompson LANCET NEUROLOGY
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
- (2015) Anthony Feinstein et al. LANCET NEUROLOGY
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- “Disease modifying nutricals” for multiple sclerosis
- (2015) Katja Schmitz et al. PHARMACOLOGY & THERAPEUTICS
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
- (2015) Hanna M. Vesterinen et al. PLoS One
- Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials
- (2014) Mickael Bonnan et al. CURRENT DRUG TARGETS
- Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis
- (2014) Marta Radaelli et al. Current Neurology and Neuroscience Reports
- Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?
- (2014) Sausan Jaber et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis
- (2014) P. De Sarno et al. JOURNAL OF IMMUNOLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Relapses and disability accumulation in progressive multiple sclerosis
- (2014) M. M. Paz Soldan et al. NEUROLOGY
- Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
- (2014) J. Romme Christensen et al. NEUROLOGY
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Neurological deficits caused by tissue hypoxia in neuroinflammatory disease
- (2013) Andrew L. Davies et al. ANNALS OF NEUROLOGY
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Disease-specific molecular events in cortical multiple sclerosis lesions
- (2013) Marie Therese Fischer et al. BRAIN
- Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis
- (2013) Damineh Morsali et al. BRAIN
- Monoclonal antibodies in treatment of multiple sclerosis
- (2013) P. S. Rommer et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Challenges in multiple sclerosis; how to define occurence of progression
- (2013) V.V. Brinar et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Novel immunoregulatory properties of EGCG on reducing inflammation in EAE
- (2013) Hong Nie Frontiers in Bioscience-Landmark
- The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse
- (2013) Sebastian M. Fiebiger et al. JOURNAL OF NEUROIMMUNOLOGY
- Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
- (2013) Krzysztof Selmaj et al. LANCET NEUROLOGY
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- A comparative study of CSF neurofilament light and heavy chain protein in MS
- (2013) Jens Kuhle et al. Multiple Sclerosis Journal
- Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions
- (2013) Corinne Brana et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Neuroprotection for acute optic neuritis—Can it work?
- (2013) R.E. Raftopoulos et al. Multiple Sclerosis and Related Disorders
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
- (2012) Peter Connick et al. LANCET NEUROLOGY
- Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
- (2012) Robert J Fox et al. Multiple Sclerosis Journal
- Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis
- (2012) B. G. Arnason et al. Multiple Sclerosis Journal
- Prolactin in multiple sclerosis
- (2012) Simon Zhornitsky et al. Multiple Sclerosis Journal
- Biotin-responsive basal ganglia disease revisited: Clinical, radiologic, and genetic findings
- (2012) B. Tabarki et al. NEUROLOGY
- Adaptive trial designs: a review of barriers and opportunities
- (2012) John A Kairalla et al. Trials
- Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
- (2011) Sandra Vergo et al. BRAIN
- Treatment of Infantile Spasms
- (2011) Carl E. Stafstrom et al. JOURNAL OF CHILD NEUROLOGY
- A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design
- (2011) Edward Fox et al. Multiple Sclerosis Journal
- Long-term results of stem cell transplantation for MS: A single-center experience
- (2011) A. Fassas et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Age and disability accumulation in multiple sclerosis
- (2011) A. Scalfari et al. NEUROLOGY
- The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
- (2011) B. Soliven et al. NEUROLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Fluoxetine protects neurons against microglial activation-mediated neurotoxicity
- (2011) Feng Zhang et al. PARKINSONISM & RELATED DISORDERS
- Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
- (2010) B.C. Cheah et al. CURRENT MEDICINAL CHEMISTRY
- Characterization of brain lesions in a mouse model of progressive multiple sclerosis
- (2010) H. Levy et al. EXPERIMENTAL NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis
- (2010) Jeremy Chataway et al. Multiple Sclerosis Journal
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- Biomarker-adaptive clinical trial designs
- (2010) Boris Freidlin et al. PHARMACOGENOMICS
- MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity
- (2010) Rebecca C. Girvan et al. VACCINE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Human Mast Cells Stimulate Activated T Cells
- (2009) Theoharis C. Theoharides et al. Annals of the New York Academy of Sciences
- Autologous T-Cell Vaccination for Multiple Sclerosis
- (2009) Arthur A Vandenbark et al. BIODRUGS
- Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis
- (2009) M. Kolappan et al. JOURNAL OF NEUROLOGY
- Prospects of repair in multiple sclerosis
- (2009) V. Wee Yong JOURNAL OF THE NEUROLOGICAL SCIENCES
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- Statins: Mechanisms of neuroprotection
- (2009) Peter J. van der Most et al. PROGRESS IN NEUROBIOLOGY
- Multi-Arm Clinical Trials of New Agents: Some Design Considerations
- (2008) B. Freidlin et al. CLINICAL CANCER RESEARCH
- LINGO-1 antagonists as therapy for multiple sclerosis:in vitroandin vivoevidence
- (2008) Richard A Rudick et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- DNA-based vaccines: the future of multiple sclerosis therapy?
- (2008) Olaf Stüve et al. Expert Review of Neurotherapeutics
- Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect
- (2008) Chae-Moon Lim et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Prolactin and dopamine: What is the connection? A Review Article
- (2008) Peter Fitzgerald et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Getting specific: monoclonal antibodies in multiple sclerosis
- (2008) Andreas Lutterotti et al. LANCET NEUROLOGY
- Neuroprotective actions of melanocortins: a therapeutic opportunity
- (2008) Anna Catania TRENDS IN NEUROSCIENCES
- Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis
- (2008) Claudia Bartels et al. Therapeutic Advances in Neurological Disorders
- Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
- (2008) Sonemany Salinthone et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis
- (2007) Arthur A. Vandenbark et al. IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now